If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKosmos Energy Regulatory News (KOS)

Share Price Information for Kosmos Energy (KOS)

Share Price is delayed by 15 minutes
Get Live Data
141.00    -3.50 (-2.28%)
Bid:
141.00
Ask:
159.00
Spread: 18.00 (12.766%)
Market Cap: £836.40m
KOS Live PriceLast checked at - London Stock Exchange

Intraday Kosmos Energy Share Chart

Director/PDMR Shareholding

7 Feb 2025 07:00

RNS Number : 2357W
Kosmos Energy Limited
07 February 2025
 

Kosmos Energy Ltd (the "Company")PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

06 February 2025

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:

PDMR

Date of transaction

No. of shares vested

No. of shares granted

No. of shares sold or withheld

Christopher J. Ball

4 February 2025

0

0

138,584

Christopher J. Ball

5 February 2025

0

0

84,898

Josh R. Marion

4 February 2025

0

0

10,379

Josh R. Marion

5 February 2025

0

0

10,354

Ronald W. Glass

4 February 2025

0

0

10,379

Ronald W. Glass

5 February 2025

0

0

10,354

Andrew G. Inglis

4 February 2025

0

0

139,002

Andrew G. Inglis

5 February 2025

0

0

138,689

Neal D. Shah

4 February 2025

0

0

78,191

Neal D. Shah

5 February 2025

0

0

78,015

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Josh R. Marion

Corporate Secretary

CONTACT:

Investor Relations

Jamie Buckland +44 203 954 2831 jbuckland@kosmosenergy.comMedia Relations

Thomas Golembeski +1-214-445-9674 tgolembeski@kosmosenergy.com

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Christopher J. Ball

b)

Position / status

SVP and Chief Commercial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

138,584 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Company's Long Term Incentive Plan (the "Plan").

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

138,584

Total

431,675.30

d)

Aggregated information 

Price

3.1149

Volume

138,584

Total

431,675.30

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

84,898 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

84,898

Total

265,043.07

d)

Aggregated information 

Price

3.1219

Volume

84,898

Total

265,043.07

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Josh R. Marion

b)

Position / status

SVP and General Counsel

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

10,379 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

10,379

Total

32,329.55

d)

Aggregated information 

Price

3.1149

Volume

10,379

Total

32,329.55

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

10,354 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

10,354

Total

32,324.15

d)

Aggregated information 

Price

3.1219

Volume

10,354

Total

32,324.15

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Ronald W. Glass

b)

Position / status

Vice President and Chief Accounting Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

10,379 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

10,379

Total

32,329.55

d)

Aggregated information 

Price

3.1149

Volume

10,379

Total

32,329.55

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

10,354 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

10,354

Total

32,324.15

d)

Aggregated information 

Price

3.1219

Volume

10,354

Total

32,324.15

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew G. Inglis

b)

Position / status

Chairman and Chief Executive Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

139,002 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

139,002

Total

432,977.33

d)

Aggregated information 

Price

3.1149

Volume

139,002

Total

432,977.33

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

138,689 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

138,689

Total

432,973.19

d)

Aggregated information 

Price

3.1219

Volume

138,689

Total

432,973.19

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Neal D. Shah

b)

Position / status

Senior Vice President and Chief Financial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

78,191 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1149

Volume

78,191

Total

243,557.15

d)

Aggregated information 

Price

3.1149

Volume

78,191

Total

243,557.15

e)

Date of the transactions

4 February 2025

f)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Stock, par value $0.01 per share

b)

Nature of the transactions

78,015 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.

Shares Granted or Vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

Currency

USD

Price

3.1219

Volume

78,015

Total

243,555.03

d)

Aggregated information 

Price

3.1219

Volume

78,015

Total

243,555.03

e)

Date of the transactions

5 February 2025

f)

Place of the transaction

NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSLFIMEISEFE
Date   Source Headline
9th Sep 20247:19 amRNSLaunch of Senior Notes Offering
9th Sep 20247:19 amRNSTender Offer
5th Aug 20247:00 amRNSSecond Quarter Results
9th Jul 20247:00 amRNSSecond Quarter 2024 Results Date
3rd Jul 20247:00 amRNSFirst Oil at Winterfell
12th Jun 20247:00 amRNSReport on Payments to Govts
10th Jun 20247:00 amRNSDirector/PDMR Shareholding
10th Jun 20247:00 amRNSResult of AGM
7th May 20247:00 amRNS1st Quarter Results
29th Apr 20247:00 amRNSReserve-Based Lending Facility Refinancing
26th Apr 20247:00 amRNSPublication of Proxy Statement
11th Apr 20247:00 amRNSFirst Quarter 2024 Results Date
6th Mar 20247:00 amRNSPricing of Senior Notes Offering
5th Mar 20247:00 amRNSOffering Of Convertible Senior Notes
26th Feb 20247:00 amRNSFourth Quarter 2023 Results
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSFourth Quarter 2023 Results Date
6th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20237:00 amRNSYakaar-Teranga Update
11th Oct 20237:00 amRNSOil Discovery In the U.S. Gulf of Mexico
6th Oct 20237:00 amRNSThird Quarter Results Date
7th Aug 20237:00 amRNSSecond Quarter Results
18th Jul 20237:00 amRNSRETIREMENT OF A PDMR
14th Jul 20237:00 amRNSStart Up of the Jubilee South East Project
6th Jul 20237:00 amRNSSecond Quarter Earnings Date
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
13th Jun 20237:00 amRNSReport on Payments to Govts
12th Jun 20237:17 amRNSResult of AGM
12th Jun 20237:00 amRNSDirector/PDMR Shareholding
9th May 20237:00 amRNS1st Quarter Results
2nd May 20237:00 amRNSPublication of Proxy Statement
27th Apr 20237:00 amRNSDirector/PDMR Shareholding
26th Apr 20237:00 amRNSNew Appointments To Board of Directors
19th Apr 20237:00 amRNS1st Quarter Results Date
27th Feb 20237:00 amRNSFourth Quarter And Full Year Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSFourth Quarter 2022 Results Date
23rd Jan 20237:15 amRNSGreater Tortue Ahmeyim FPSO Sailaway
15th Nov 20224:41 pmRNSSecond Price Monitoring Extn
15th Nov 20224:36 pmRNSPrice Monitoring Extension
11th Nov 20226:00 pmRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNS3rd Quarter Results
18th Oct 20227:00 amRNS3rd Quarter Earnings Date
27th Sep 20227:00 amRNSTortue FPSO Update
19th Sep 20227:00 amRNSUpdate on Greater Tortue Ahmeyim FPSO
8th Aug 20227:00 amRNS2nd Quarter Results
21st Jul 20227:00 amRNSSecond Quarter 2022 Results Date
27th Jun 20227:00 amRNSReport on Payments to Govts
14th Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.